IGF1 is a modifier of disease risk in hereditary non‐polyposis colorectal cancer
Stuart G. Reeves(Hunter Medical Research Institute), Rodney J. Scott(New South Wales Department of Health), Cliff Meldrum(New South Wales Department of Health), Janina Suchy(International Hereditary Cancer Center), Dominique Rich(Hunter Medical Research Institute), Kim Colyvas(University of Newcastle Australia), Jan Lubiński(Tumour Institute of Tuscany), Grzegorz Kurzawski(International Hereditary Cancer Center)
Cited by 25
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
|Nature Genetics|2014|486